September 24, 2024
Otsuka Pharmaceutical Co., Ltd.
National Cancer Center Japan
Kyushu University
Kyoto University
Nagoya Medical Center, National Hospital Organization
The Institute of Medical Science, The University of Tokyo
´ºÓêÖ±²¥app School of Medicine
We are pleased to announce that Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo; hereinafter "Otsuka Pharmaceutical") has obtained manufacturing and marketing approval in Japan for Hemsite?, a gene panel test for hematologic malignancies. Hemsite? was co-designed by Otsuka Pharmaceutical and the National Cancer Center Japan (Location: Tokyo; hereinafter "NCCJ") and developed by a joint research consortium with the NCCJ, Kyushu University (Location: Fukuoka Prefecture), Kyoto University (Location: Kyoto Prefecture), Nagoya Medical Center, National Hospital Organization (Location: Aichi Prefecture), the Advanced Clinical Research Center at The Institute of Medical Science, The University of Tokyo (Location: Tokyo), and ´ºÓêÖ±²¥app School of Medicine (Location: Tokyo). Moving forward, we will proceed with procedures for insurance coverage and prepare for its launch.
Please see below for the full press release.